Hospital-based opioid treatment: Expanding and sustaining the model in Texas | Canada Hyperbarics Skip to main content
Study J Hosp Med 2023

Hospital-based opioid treatment: Expanding and sustaining the model in Texas

Moriates C, Boulton A, Walker B, Holliman R, Christian N, Weems J, et al. — J Hosp Med, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers looked at how well a hospital program for opioid addiction worked and expanded in Texas.

What They Found

The B-Team started 398 patients on buprenorphine therapy and coordinated outpatient care for 353 patients from September 2018 to January 2023. Of eligible patients, 36% (73 patients) continued appointments 6-12 months post-discharge, and 22% (40 patients) continued after one year. The model expanded to three more hospitals, treating 1037 patients across four sites in 2021-2022.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This brief report presents observational follow-up data from a specific region, which may not be generalizable to all populations or healthcare systems.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 37876117
Year Published 2023
Journal J Hosp Med
MeSH Terms Humans; Analgesics, Opioid; Opiate Substitution Treatment; Texas; Buprenorphine; Opioid-Related Disorders; Hospitals

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.